ONE-WAYOngoing theme · still written in the latest filings
U.S. Clinical Development of TDM-711 and Expansion of Bone Regeneration Applications
A program to advance the next phase of clinical trials for the alveolar bone reconstruction material TDM-711 in the United States, expand its applications to an injectable bone void filler for large bone defects, and seek early regulatory approval.
Companies1How many companies write about this.
Threads1One company can carry more than one thread here.